Search

everythinglearnresearchcommunity

for

Search:↓

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Oxytocin receptors are found in skin cells near touch and pain neurons.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.